Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Atea Pharmaceuticals (AVIR) SEC Filings & 10K Form

Atea Pharmaceuticals logo
$3.49 -0.01 (-0.29%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$3.48 -0.01 (-0.14%)
As of 08/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Atea Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/24/2025
5:00 PM		Atea Pharmaceuticals (Issuer)
Berman Howard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2025
5:05 PM		Atea Pharmaceuticals (Issuer)
Berman Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM		Atea Pharmaceuticals (Issuer)
Lucidi Bruno (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM		Adams Jerome M. (Reporting)
Atea Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM		Atea Pharmaceuticals (Issuer)
Polsky Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM		Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM		Atea Pharmaceuticals (Issuer)
Duncan Barbara Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:05 PM		Atea Pharmaceuticals (Issuer)
Murphy Polly A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
4:16 PM		Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
5:21 PM		Atea Pharmaceuticals (Subject)
Sommadossi Jean-Pierre (Filed by)
Form SCHEDULE 13G/A
05/12/2025
3:45 PM		Atea Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2025
4:00 PM		Atea Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
7:14 PM		Atea Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/17/2025
11:23 AM		Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form SCHEDULE 13D/A
04/17/2025
7:06 AM		Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:50 PM		Atea Pharmaceuticals (Filer)
Form DEFA14A
04/01/2025
8:21 AM		Atea Pharmaceuticals (Filer)
Form DEFA14A
04/01/2025
8:19 AM		Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
4:15 PM		Atea Pharmaceuticals (Filer)
Form DEFA14A
03/26/2025
1:30 PM		Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form DFAN14A
03/24/2025
5:16 AM		Atea Pharmaceuticals (Filer)
Form DEFA14A
03/24/2025
5:10 AM		Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
10:58 AM		Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form SCHEDULE 13D/A
03/06/2025
3:45 PM		Atea Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
8:27 AM		Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
Form SCHEDULE 13D
02/24/2025
5:52 PM		Atea Pharmaceuticals (Issuer)
Kirsch Arthur S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:47 PM		Atea Pharmaceuticals (Issuer)
Kirsch Arthur S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/24/2025
7:17 AM		Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
11:47 AM		Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
5:00 PM		Atea Pharmaceuticals (Issuer)
Foster Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM		Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM		Atea Pharmaceuticals (Issuer)
Corcoran Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM		Atea Pharmaceuticals (Issuer)
Horga Maria Arantxa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM		Atea Pharmaceuticals (Issuer)
Vavricka John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
5:00 PM		Atea Pharmaceuticals (Issuer)
Hammond Janet MJ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
1:30 PM		Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4/A
01/17/2025
7:03 AM		Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:50 AM		Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13D
12/12/2024
5:00 PM		Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:17 PM		Atea Pharmaceuticals (Subject)
BERGER FRANKLIN M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
11:15 PM		Atea Pharmaceuticals (Filer)
Form EFFECT
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
11/15/2024
9:34 AM		Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/07/2024
3:58 PM		Atea Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/07/2024
3:41 PM		Atea Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
3:27 PM		Atea Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
7:02 PM		Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:22 PM		Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:09 PM		Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
3:16 PM		Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AVIR) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored